Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.320
-0.020 (-0.46%)
Apr 24, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biotechnology
7.95M3.55M6.00M--
Biotechnology Growth
123.57%-40.79%---
Total
7.95M3.55M6.00M--
Total Growth
123.57%-40.79%---

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
7.95M3.55M6.00M--
United States Growth
123.57%-40.79%---
Total
7.95M3.55M6.00M--
Total Growth
123.57%-40.79%---
Source: S&P Global Market Intelligence.